NCT07762066 Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men
| NCT ID | NCT07762066 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fenway Community Health |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-05-06 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-05-06 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Older gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. B2B is a peer-delivered, manualized program designed to increase engagement in LGBTQ+-affirming elder services and thereby reduce loneliness and depression among OGBMLH. The program utilizes a) cognitive behavioral therapy-based Friendship Enrichment Program (FEP) to build social skills; b) Peer Mentoring (PM) to model and support engagement in community services; and c) connecting participants to affirming elder services such as meal programs, bereavement groups, social activities, etc. Interventions like B2B are essential to the NIH's goal of improving access to behavioral interventions through advances in HIV/AIDS research.
Eligibility Criteria
Inclusion Criteria: * HIV+ and provide evidence or documentation of HIV+ status * Willing to release HIV-related health records * Self-identify as a man who has sex with men * Able to provide informed consent in English * Be ≥50 years old * Score at least a 2 on the PHQ-2 OR score at least a 4 on the UCLA Shortened Loneliness Scale Exclusion Criteria: * HIV- * Does not self-identify as a man who has sex with men * Is less than 50 years old * Scores less than 2 on the PHQ-2 AND scores less than 4 on the UCLA Shortened Loneliness Scale
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07762066 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07762066 currently recruiting?
Yes, NCT07762066 is actively recruiting participants. Contact the research team at abigail.batchelder@bmc.org for enrollment information.
Where is the NCT07762066 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07762066 clinical trial?
NCT07762066 is sponsored by Fenway Community Health. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.